ERRIN

Post-LOE

norethindrone

Dr. Reddy's Laboratories

ANDAORAL-28TABLET

Approved

Oct 2002

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

5/8 — Partial

ERRIN (norethindrone) by Dr. Reddy's Laboratories is 1. Approved for pregnancy. First approved in 2002.

Drug data last refreshed 18h ago

$0.0BPart D

Mechanism of Action

1. Mode of Action Errin progestin-only oral contraceptives prevent conception by suppressing ovulation in approximately half of users, thickening the cervical mucus to inhibit sperm penetration, lowering the midcycle LH and FSH peaks, slowing the movement of the ovum through the fallopian tubes,…

Pharmacologic Class:

Progestin

Indications (1)

pregnancy

Clinical Trials (20)

NCT07293728Phase 4Not Yet Recruiting

A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia

Started Jul 2026

50 enrolled

HypertensionPreeclampsia

NCT07446400Phase 1Recruiting

A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

Started Mar 2026

48 enrolled

Healthy Volunteers

NCT06911632N/AActive Not Recruiting

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Started Jul 2025

1,000 enrolled

Pulmonary HypertensionInterstitial Lung Disease (ILD)

NCT04882137N/AWithdrawn

Barriers to Referring Adolescent Women for Etonogestrel Implant.

Started Sep 2023

Contraceptive Usage

NCT05519254Phase 3Recruiting

Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae

Started Mar 2023

600 enrolled

DiarrheaWastingMalnutrition, Child

Worked on ERRIN at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.